Anaplastic Astrocytoma
📧 Sign up to get email alerts when something new happens for Anaplastic Astrocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
This trial update describes a pediatric brain tumor study using cerebrospinal fluid cell-free tumor DNA; the study was terminated.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant [Phase 2]
Phase 2 clinical trial exploring ribociclib with everolimus or with temozolomide for high-grade gliomas and related diffuse gliomas; recruit…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma [Phase 1]
This clinical trial investigates temozolomide (Temodar) in combination with the HDAC inhibitor Abexinostat for recurrent high-grade gliomas,…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma [Phase 2]
A Phase 2 clinical trial update examining the combination of dabrafenib and trametinib after radiation therapy for newly diagnosed high-grad…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA [Phase 2]
Phase 2 clinical trial investigating super selective intra-arterial cetuximab with reirradiation for relapsed or refractory glioblastoma, an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Phase 1]
Phase 1 clinical trial update exploring vorinostat with temozolomide for malignant gliomas in adults, with active-not-recruiting status acro…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma [Phase 1]
A Phase 1 pediatric trial of SurVaxM for progressive or relapsed medulloblastoma, high-grade glioma, ependymoma, and newly diagnosed diffuse…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Pediatric Long-Term Follow-up and Rollover Study [Phase 4]
Pediatric long-term follow-up and rollover study (Phase 4) sponsored by Novartis is active but not recruiting, tracking outcomes in children…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Targeted Pediatric High-Grade Glioma Therapy
A pediatric clinical trial is currently recruiting to evaluate a targeted therapy for high-grade gliomas, including diffuse intrinsic pontin…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating HSV-tk gene therapy with valacyclovir and SBRT plus chemotherapy for recurrent glioblastoma and…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HSV-tk gene therapy in combination with radiotherapy and chemotherapy for newly diagnosed glioblastoma…
-
CLINICAL_TRIALS other · 2026-03-30Clinical Trial Update: WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases [Phase 1]
Phase 1 clinical trial update for WSD0922-FU evaluating safety and preliminary activity in glioblastoma, anaplastic astrocytoma, and non-sma…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion [EARLY_Phase 1]
A Phase 1 study assessing lorlatinib for newly diagnosed high-grade gliomas with ALK or ROS1 fusions; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma [Phase 1]
Phase 1 trial evaluating mesenchymal stem cell-delivered DNX-2401 for recurrent high-grade glioma. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas
This clinical trial update reports a comprehensive analysis of chemotherapy and targeted therapy outcomes in recurrent malignant gliomas, in…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) [Phase 1]
A Phase 1 trial evaluating the safety of combining 5-ALA with the CV01 ultrasound delivery system for sonodynamic therapy in patients with n…
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma [NA]
Ongoing clinical trial evaluating intensity-modulated stereotactic radiotherapy for patients with grade II–IV gliomas, including glioblastom…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) [Phase 1]
Phase 1 study evaluating re-administration of C134 in patients with recurrent glioblastoma and related brain gliomas has been terminated.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study of Pembrolizumab and M032 (NSC 733972) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating pembrolizumab in combination with M032 for glioblastoma, anaplastic astrocytoma, and gliosarcom…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma [Phase 2]
Phase 2 clinical trial evaluating Gallium-68 PSMA-11 PET/CT for detecting recurrence or progression in high-grade gliomas (WHO Grade 3 and G…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma [Phase 1]
A Phase 1 clinical trial in pediatric patients with recurrent high-grade glioma evaluating hematopoietic stem cell therapy in combination wi…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms [Phase 1]
Phase I trial update indicates ONC206 is being studied for recurrent and rare primary central nervous system neoplasms and the study is curr…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for relapsed/refractory intracranial glioma in patients under 22 years, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. [Phase 1]
Phase 1 trial of the multi-kinase inhibitor TG02 in elderly newly diagnosed or adult relapsed patients with anaplastic astrocytoma or gliobl…